(Q50110124)

25 February 2018

meta-analysis

0 references

title

A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania (English)

1 reference

25 February 2018

author

Eduard Vieta

3

1 reference

25 February 2018

author name string

A Yildiz

1

1 reference

25 February 2018

M Nikodem

2

1 reference

25 February 2018

C U Correll

4

1 reference

25 February 2018

R J Baldessarini

5

1 reference

25 February 2018

language of work or name

English

0 references

publication date

18 July 2014

1 reference

25 February 2018

published in

Psychological Medicine

1 reference

25 February 2018

volume

45

1 reference

25 February 2018

issue

2

1 reference

25 February 2018

page(s)

299-317

1 reference

25 February 2018

Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Excess mortality in bipolar and unipolar disorder in Sweden

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Evaluation of networks of randomized trials

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Head to head comparisons as an alternative to placebo-controlled trials.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

International consensus study of antipsychotic dosing.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

A diagnostic interview: the schedule for affective disorders and schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Indirect comparison: relative risk fallacies and odds solution

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Indirect comparisons of competing interventions

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Checking consistency in mixed treatment comparison meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Bayesian methods for evidence synthesis in cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Can bipolar disorder be viewed as a multi-system inflammatory disease?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Suicidal risks among 2826 Sardinian major affective disorder patients.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Antipsychotic switching in bipolar disorders: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

A simple method for converting an odds ratio to effect size for use in meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd).

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Confidence intervals for the number needed to treat

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Verapamil versus lithium in acute mania

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Carbamazepine compared to haloperidol in acute mania

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Olanzapine vs. lithium in management of acute mania

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Subgenual prefrontal cortex abnormalities in mood disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Bayesian measures of model complexity and fit

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Factors modifying drug and placebo responses in randomized trials for bipolar mania.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Life expectancy among persons with schizophrenia or bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Assessing Clinical Characteristics of the Manic State

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Lamotrigine: a review of its use in bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Research diagnostic criteria: rationale and reliability

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Combination of direct and indirect evidence in mixed treatment comparisons

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Comparison between lithium and valproate in the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

A double-blind comparison of valproate and lithium in the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001305

7 January 2021

10.1017/S0033291714001305

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018